Published in APMIS on September 01, 1995
Phenotypic and genotypic characterization of coagulase-negative staphylococci isolated in blood cultures from patients with haematological malignancies. Eur J Clin Microbiol Infect Dis (2006) 0.86
Colonization pattern of coagulase-negative staphylococci in preterm neonates and the relation to bacteremia. Eur J Clin Microbiol Infect Dis (2010) 0.83
Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis (2011) 0.79
Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet (1982) 3.64
The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci U S A (1994) 3.02
Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli. Lancet (1981) 2.76
Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis (2000) 2.37
Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis. Pediatr Clin North Am (1982) 2.33
Structure of the IgG-binding regions of streptococcal protein G. EMBO J (1986) 2.20
Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis (1985) 2.16
Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea. J Med Microbiol (1984) 2.07
A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun (1998) 2.06
In vitro adhesion of uropathogenic Escherichia coli to human periurethral cells. Infect Immun (1980) 1.98
Expression of collagen-binding protein and types 5 and 8 capsular polysaccharide in clinical isolates of Staphylococcus aureus. J Infect Dis (1997) 1.96
Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis (1996) 1.94
Enterotoxin-producing bacteria and parasites in stools of Ethiopian children with diarrhoeal disease. Arch Dis Child (1976) 1.94
Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test. Infection (1982) 1.88
Purification and some properties of a heat-labile enterotoxin from escherichia coli. Zentralbl Bakteriol Orig A (1974) 1.83
Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. J Infect Dis (2000) 1.80
Sensitive assay for detection of toxin-induced damage to the cytoplasmic membrane of human diploid fibroblasts. Infect Immun (1975) 1.78
Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol Microbiol (1994) 1.77
Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman. Microb Pathog (1992) 1.76
Evaluation of a ganglioside immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1979) 1.70
Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol (1999) 1.69
Rapid grouping of streptococci by immunoelectroosmophoresis. Med Microbiol Immunol (1974) 1.67
Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection (1980) 1.66
Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis (1991) 1.65
Carbohydrate receptor structures recognized by uropathogenic E. coli. Scand J Infect Dis Suppl (1982) 1.63
Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine (1999) 1.63
Cloning, sequencing and expression of subtilisin Carlsberg from Bacillus licheniformis. Nucleic Acids Res (1985) 1.61
Characterization of Aeromonas spp. isolated from humans with diarrhea, from healthy controls, and from surface water in Bangladesh. J Clin Microbiol (1997) 1.59
Antibody response in Staphylococcus aureus septicaemia--a prospective study. J Med Microbiol (1998) 1.58
P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection (1983) 1.57
Separation of two hemolysins from Aeromonas hydrophila by isoelectric focusing. Infect Immun (1971) 1.57
Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect Immun (1989) 1.56
Effects of staphylococcal alpha-, beta-, delta-, and gamma-hemolysins on human diploid fibroblasts and HeLa cells: evaluation of a new quantitative as say for measuring cell damage. Infect Immun (1973) 1.54
Production and purification of Streptococcus pneumoniae hemolysin (pneumolysin). J Clin Microbiol (1987) 1.54
Enzyme-linked immunosorbent assay for antibodies against teichoic acid in patients with staphylococcal infections. J Clin Microbiol (1983) 1.51
Enterotoxigenic Escherichia coli and other gram-negative bacteria of infantile diarrhea: surface antigens, hemagglutinins, colonization factor antigen, and loss of enterotoxigenicity. J Infect Dis (1980) 1.51
Does surface heparinisation reduce bacterial colonisation of central venous catheters? Lancet (1995) 1.49
Biochemical fingerprinting of water coliform bacteria, a new method for measuring phenotypic diversity and for comparing different bacterial populations. Appl Environ Microbiol (1991) 1.47
Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect Immun (1996) 1.46
Preoperative antibiotics and capsular contracture in augmentation mammaplasty. Plast Reconstr Surg (1990) 1.45
The role of antibodies against alpha-toxin and teichoic acid in the diagnosis of staphylococcal infections. Infection (1983) 1.45
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine (1990) 1.43
Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod (2000) 1.40
Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog (1993) 1.40
Determination of toxin-induced leakage of different-size nucleotides through the plasma membrane of human diploid fibroblasts. Infect Immun (1975) 1.39
Separation and characterization of enterotoxin and two haemolysins from Aeromonas hydrophila. Acta Pathol Microbiol Scand B (1981) 1.38
Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policy. J Clin Microbiol (1988) 1.36
Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin). J Clin Microbiol (1987) 1.35
Receptors for pyelonephritogenic Escherichia coli in primates. J Urol (1984) 1.34
Nucleotide sequence of rfaI and rfaJ genes encoding lipopolysaccharide glycosyl transferases from Salmonella typhimurium. Nucleic Acids Res (1990) 1.33
Virulence factors in Escherichia coli strains isolated from Swedish piglets with diarrhea. J Clin Microbiol (1988) 1.32
Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen. J Biol Chem (1998) 1.32
Urinary Escherichia coli causing recurrent infections--a prospective follow-up of biochemical phenotypes. Clin Nephrol (1992) 1.30
Occurrence, diversity, and pathogenicity of halophilic Vibrio spp. and non-O1 Vibrio cholerae from estuarine waters along the Italian Adriatic coast. Appl Environ Microbiol (1999) 1.30
Purification of phospholipase C (alpha-toxin) from Clostridium perfringens. Biochim Biophys Acta (1973) 1.28
Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis (1991) 1.27
Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model. J Immunol Methods (1995) 1.27
Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat. Vaccine (2001) 1.27
Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica. Diagn Microbiol Infect Dis (1993) 1.26
Deletion mutants of temperate Bacillus subtilis bacteriophage phi105. Mol Gen Genet (1977) 1.26
Studies on Escherichia coli in pigs V. Determination of enterotoxicity and frequency of O groups and K 88 antigen in strains from 200 piglets with neonatal diarrhoea. Zentralbl Veterinarmed B (1978) 1.25
Phenotypic characterization of intestinal Escherichia coli of pigs during suckling, postweaning, and fattening periods. Appl Environ Microbiol (1995) 1.24
Phenotypic variations among enterotoxinogenic Escherichia coli from Swedish piglets with diarrhoea. Med Microbiol Immunol (1985) 1.24
Treatment of myxoedema coma--factors associated with fatal outcome. Acta Endocrinol (Copenh) (1985) 1.23
The effect of zinc oxide supplementation on the stability of the intestinal flora with special reference to composition of coliforms in weaned pigs. J Appl Microbiol (1999) 1.20
Attempts to control clothes-borne infection in a burn unit. I. Experimental investigations of some clothes for barrier nursing. J Hyg (Lond) (1977) 1.20
Classification of microbial, plant and animal cytolysins based on their membrane-damaging effects of human fibroblasts. Biochim Biophys Acta (1979) 1.19
Phenomenon of hot-cold hemolysis: chelator-induced lysis of sphingomyelinase-treated erythrocytes. Infect Immun (1975) 1.19
Serum antibody response to Clostridium difficile toxins in patients with Clostridium difficile diarrhoea. Infection (1985) 1.18
Enterotoxins, O-groups, and K88 antigen in Escherichia coli from neonatal piglets with and without diarrhea. Infect Immun (1979) 1.18
Some biological properties of purified staphylococcal haemolysins. Toxicon (1972) 1.17
Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D. J Gen Microbiol (1976) 1.17
Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis. Acta Paediatr Scand (1986) 1.15
Immunological relation between serum antibodies against pneumolysin and against streptolysin O. Acta Pathol Microbiol Immunol Scand B (1987) 1.14
Formation of phospholipase C and theta-haemolysin in pre-reduced media in batch anc continuous culture of Clostridium perfringens type A. J Gen Microbiol (1974) 1.14
Lack of fbe, the gene for a fibrinogen-binding protein from Staphylococcus epidermidis, reduces its adherence to fibrinogen coated surfaces. Microb Pathog (2001) 1.13
Biological activities contaminating preparations of phospholipase C ( -toxin) from Clostridium perfringens. Toxicon (1973) 1.13
Consequences of spingomyelin degradation in erythrocyte ghost membranes by staphylococcal beta-toxin (sphingomyelinase C). Toxicon (1974) 1.12
Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr (1996) 1.10
Colonization and persistence of Escherichia coli phenotypes in the intestines of children aged 0 to 18 months. Infection (1986) 1.10
Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonisation of S. aureus in a mouse mastitis model. FEMS Immunol Med Microbiol (1994) 1.10
Validation of nested Bordetella PCR in pertussis vaccine trial. J Clin Microbiol (1996) 1.10
An international study of patient compliance with hemodialysis. JAMA (1999) 1.09
Evaluation of numerical typing systems for Escherichia coli using the API 50 CH and the PhP-EC systems as models. Epidemiol Infect (1990) 1.09
Occurrence, diversity and pathogenicity of mesophilic Aeromonas in estuarine waters of the Italian coast of the Adriatic Sea. J Appl Microbiol (1998) 1.09
[Dialysis treatment is satisfactory. A survey of all patients with chronic renal failure in Stockholm]. Lakartidningen (1995) 1.08
Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed (1997) 1.08
Functional studies of a fibrinogen binding protein from Staphylococcus epidermidis. Infect Immun (1999) 1.07
Cytotoxic effects on the plasma membrane of human diploid fibroblasts--a comparative study of leakage tests. Med Biol (1976) 1.06
Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function. Nephron (1994) 1.05
Antibiotic prophylaxis in pacemaker surgery: a prospective double blind trial with systemic administration of antibiotic versus placebo at implantation of cardiac pacemakers. Pacing Clin Electrophysiol (1986) 1.05